AirAvant Medical is a research-oriented, privately held company that focuses on developing and marketing innovative respiratory medical devices to treat obstructive sleep apnea and other breathing disorders. AirAvant has recently launched the Bongo® Rx, a groundbreaking EPAP device that is FDA-cleared to treat mild to moderate obstructive sleep apnea.
Holding numerous patents with several patents pending, AirAvant Medical continues to innovate revolutionary respiratory technologies for the sleep-disorder breathing market, which includes Obstructive Sleep Apnea, snoring, and COPD applications.
AirAvant Medical was founded by Bruce Sher, Shara Hernandez, Javier Collazo, and Ron Richard. The company’s founders were former executives at InnoMed Technologies, Inc., where they had developed and launched a highly acclaimed line of respiratory and sleep devices, including the Nasal-Aire, the Hybrid, and the Aloha CPAP interfaces. In 2019, AirAvant Medical introduced its flagship product – the Bongo® Rx.
Our company will continue developing cutting-edge respiratory medical devices to meet the demand for user-friendly design and effective treatment in the sleep-disorder breathing market. AirAvant Medical is committed to delivering innovative products, high product quality, and excellent customer service.
Meet The Founders
Co-Founder | Co-President
Co-Founder | Co-President
Co-Founder | Vice-President | General Manager
Meet The Medical Technology Advisory Committee
Jerrold Kram, MD, FAASM
Medical Director at California Center for Sleep Disorders
Alan Lankford, PhD, FAASM
Sleep Medicine Clinician/Scientist, Director of Research at The Neurological Center of North Georgia and Chief Science Officer at SleepSafe Drivers
Rafael Pelayo, MD, FAASM
Clinical Professor, Sleep Medicine Division at Stanford University School of Medicine and 2020 President-elect at California Sleep Society
Lynn M. Schmidt, PhD, RN, CNE
Dean, Nursing & Kinesiology at Anderson University
Why The Bongo® Rx Was Developed
A Treatment for Obstructive Sleep Apnea
AirAvant Medical conceived the Bongo Rx as a discreet and user-friendly EPAP device to treat sleep apnea. AirAvant Medical (a DBA of InnoMed Healthscience) is registered with the U.S. Food and Drug Administration and its Bongo Rx has received FDA 510(k) Clearance for the treatment of mild to moderate obstructive sleep apnea (OSA).
An Alternative to CPAP Therapy
Patients must cope with a strenuous breathing experience, bedside nuisance of the electronic equipment, obtrusive hoses, and bulky masks. Many patients ultimately find that they cannot adapt to CPAP and subsequently give up on treatment.
AirAvant believes that its Bongo Rx EPAP device provides patients and providers with a viable non-surgical alternative to CPAP, for cases where either (a) CPAP is not an effective option due to non-compliance or (b) the patient is seeking a treatment that is more convenient and less obtrusive than CPAP.